Neither Brca2Tr/WT mice (Friedman et al., 1998), nor strains heterozygous for other Brca2 truncation mutants (Connor et al., 1997; Sharan et al., 1997; Jonkers et al., 2001; Yan et al., 2004), exhibit cancer predisposition. The gene discussed is BRCA2; the disease is cancer.